We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
(+157%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
58.75%
Top 10 Holdings %
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$895K |
| 2 |
Photronics
PLAB
|
+$774K |
| 3 |
Edwards Lifesciences
EW
|
+$755K |
| 4 |
Maximus
MMS
|
+$754K |
| 5 |
Tetra Tech
TTEK
|
+$745K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$197K |
| 2 |
CoStar Group
CSGP
|
+$197K |
| 3 |
Vista Energy
VIST
|
+$197K |
| 4 |
SKX
Skechers
SKX
|
+$196K |
| 5 |
Alerus Financial
ALRS
|
+$195K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.59% |
| 3 | Industrials | 17.43% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Financials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Tencent Music
TME
$14.5B
| $173K | 0.1% |
14,340
+10,064
| +235% | +$123K |
|
502
CryoPort
CYRX
$775M
| $172K | 0.1% |
+21,183
| New | +$173K |
|
503
Acadia Pharmaceuticals
ACAD
$4.25B
| $169K | 0.1% |
10,970
+3,544
| +48% | +$59.1K |
|
504
Warby Parker
WRBY
$3.01B
| $168K | 0.1% |
+10,264
| New | +$155K |
|
505
Dana Inc
DAN
$2.91B
| $167K | 0.09% |
+15,800
| New | +$174K |
|
506
Arcutis Biotherapeutics
ARQT
$3.42B
| $165K | 0.09% |
17,774
+11,202
| +170% | +$111K |
|
507
Weave Communications
WEAV
$491M
| $164K | 0.09% |
+12,821
| New | +$135K |
|
|
OLPX
508
DELISTED
Olaplex Holdings
OLPX
| $162K | 0.09% |
+69,094
| New | +$140K |
|
509
New Fortress Energy
NFE
$101M
| $162K | 0.09% |
+17,841
| New | +$275K |
|
510
Absci
ABSI
$1.28B
| $158K | 0.09% |
+41,259
| New | +$164K |
|
511
MannKind Corp
MNKD
$1.28B
| $156K | 0.09% |
+24,804
| New | +$143K |
|
512
Real Brokerage
REAX
$368M
| $153K | 0.09% |
+27,631
| New | +$157K |
|
513
Tango Therapeutics
TNGX
$4.34B
| $153K | 0.09% |
+19,839
| New | +$189K |
|
514
Teladoc Health
TDOC
$1.58B
| $151K | 0.09% |
+16,452
| New | +$136K |
|
515
Alight
ALIT
$497M
| $150K | 0.09% |
+1,013
| New | +$145K |
|
516
Mitsubishi UFJ Financial
MUFG
$258B
| $149K | 0.08% |
14,593
+10,810
| +286% | +$114K |
|
517
Viasat
VSAT
$9.79B
| $145K | 0.08% |
+12,169
| New | +$196K |
|
|
VISN
518
Vistance Networks Inc
VISN
$2.66B
| $144K | 0.08% |
+23,601
| New | +$80.9K |
|
519
Roivant Sciences
ROIV
$25.2B
| $144K | 0.08% |
12,479
+11,331
| +987% | +$129K |
|
520
Treace Medical Concepts
TMCI
$259M
| $144K | 0.08% |
+24,788
| New | +$159K |
|
521
Resources Connection
RGP
$129M
| $142K | 0.08% |
14,652
+14,317
| +4,274% | +$148K |
|
522
Sutro Biopharma
STRO
$379M
| $142K | 0.08% |
+4,099
| New | +$161K |
|
523
Cerus
CERS
$587M
| $141K | 0.08% |
+81,200
| New | +$170K |
|
|
ACCD
524
DELISTED
Accolade Inc
ACCD
| $141K | 0.08% |
+36,674
| New | +$144K |
|
525
Leslie's
LESL
$11.6M
| $141K | 0.08% |
+2,225
| New | +$137K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q3 2024 Portfolio in Review
As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.
- EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
- EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
- EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
- EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
- EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
- EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
- EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.
Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.